Michael J. Fox, 62, says he doesn't 'fear' death amid 30-year battle with Parkinson's: 'One day I'll...

The Back to the Future alum, 62, who was first diagnosed in 1991 at age 29 told Town & Country: 'One day I’ll run out of gas. One day I’ll just say,"It’s not going to happen. I’m not going out today. If that comes, I’ll allow myself that. I’m 62 years old.'

Fox has previously told how 2018 was one of his worst years after he had spinal cord surgery to remove a benign tumour and then broke his arm soon afterwards. Michael has been living with Parkinson's disease since his diagnosis at 29 in 1991, while he went public with the news in 1998, and has devoted himself to finding a cure through his foundation.He retired from acting in 2020 due to his symptoms - which have included tremors, impaired movement, coordination and muscle stiffness.Earlier this year, Michael spoke candidly about the painful realities of living with the disorder in an interview with CBS Sunday Mornings.

Parkinson's disease is a condition in which parts of the brain become progressively damaged over many years, according to the NHS website.The NHS says there are three major symptoms, including tremors or shaking, slowness of movement and muscle stiffness. Some scientists believe a combination of genetic and environmental factors are the cause of Parkinson's disease.However, it is not known why the loss of nerve cells associated with the condition takes place but research is ongoing to identify potential causes.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

CU professor of ophthalmology receives grant to study Parkinson's disease biomarkersFor some, the eyes are a window into the soul. But for Jayashree Kalpathy-Cramer, PhD, professor of ophthalmology at the University of Colorado School of Medicine, they're a window into human health.
Source: NewsMedical - 🏆 19. / 71 Read more »

Circuit-specific gene therapy brings new hope for treatment of Parkinson's diseaseResearchers from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences (CAS) and their collaborators have developed a gene therapy strategy to selectively manipulate Parkinson's disease-affected circuitry and attenuate the core motor symptoms of Parkinson's disease in rodent and nonhuman primate animals.
Source: medical_xpress - 🏆 101. / 51 Read more »